A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions

Porcine circovirus type 2 (PCV2) vaccination has been effective in protecting pigs from clinical disease and today is used extensively. Recent studies in vaccinated populations indicate a major PCV2 genotype shift from the predominant PCV2 genotype 2b towards 2d. The aims of this study were to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Opriessnig, Tanja, Xiao, Chao-Ting, Halbur, Patrick G., Gerber, Priscilla F., Matzinger, Shannon R., Meng, Xiang-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221148/
https://www.ncbi.nlm.nih.gov/pubmed/27919634
http://dx.doi.org/10.1016/j.vaccine.2016.11.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221148/
https://www.ncbi.nlm.nih.gov/pubmed/27919634
http://dx.doi.org/10.1016/j.vaccine.2016.11.085

Ejemplares similares